Invested in Kadance, a genomics-based precision health management program integrating hereditary cancer risk testing into insurance products.
Kadance offers personalized insights into genetic cancer risk and medication responses, providing affordable access to precision health management
Kadance offers personalized insights into genetic cancer risk and medication responses, providing affordable access to precision health management.